Selected Publications
Blay JY, Palmerini E, Bollard J, Aguiar S, Angel M, Araya B, Badilla R, Bernabeu D, Campos F, Chs CS, Carvajal Montoya A, Casavilca-Zambrano S, Castro-Oliden 5th, Chacon M, Clara-Altamirano MA, Collini P, Correa Genoroso R, Costa FD, Cuellar M, Dei Tos AP, Dominguez Malagon HR, Donati DM, Dufresne A, Eriksson M, Farias-Loza M, Frezza AM, Frisoni T, Garcia-Ortega DY, Gerderblom H, Gouin F, Gomez-Mateo MC, Gronchi A, Haro J, Hindi N, Huanca L, Jimenez N, Karanian M, Kasper B, Lopes A, Lopes David BB, Lopez-Pousa A, Lutter G, Maki RG, Martinez-Said H, Martinez-Tlahuel JL, Mello CA, Morales Perez JM, Moura DS, Nakagawa SA, Nascimento AG, Ortiz-Cruz EJ, Patel S, Pfluger Y, Provenzano S, Righi A, Rodriguez A, Santos TG, Scotlandi K, Mlg S, Soule T, Stacchiotti S, Valverde CM, Waisberg F, Zamora Estrada E, Martin-Broto J.: Corrigendum to "SELNET clinical practice guidelines for bone sarcoma" Critical reviews in oncology/hematology, vol. 174 (2022), 1-10 Crit Rev Oncol Hematol 180 : 103827,2022.
Rosenbaum E, Chugh R, Ryan CW, Agulnik M, Milhem MM, George S, Jones RL, Chmielowski B, Van Tine BA, Tawbi H, Elias AD, Read WL, Budd GT, Qin LX, Rodler ET, Hirman J, Weiden P, Bennett CM, Livingston PO, Ragupathi G, Hansen D, D'Angelo SP, Tap WD, Schwartz GK, Maki RG, Carvajal RD.: A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery Eur J Cancer 176 : 155-163,2022.
Blay, J. Y., Duffaud, F., George, S., Maki, R. G., Penel, N.: Regorafenib for the Treatment of Sarcoma Curr Treat Options Oncol 23 (11): 1477-1502,2022.
Rosenbaum, E., Chugh, R., Ryan, C. W., Agulnik, M., Milhem, M. M., George, S., Jones, R. L., Chmielowski, B., Van Tine, B. A., Tawbi, H., Elias, A. D., Read, W. L., Budd, G. T., Qin, L. X., Rodler, E. T., Hirman, J., Weiden, P., Bennett, C. M., Livingston, P. O., Ragupathi, G., Hansen, D., D'Angelo, S. P., Tap, W. D., Schwartz, G. K., Maki, R. G., Carvajal, R. D.: A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery Eur J Cancer 176 : 155-163,2022.
Stacchiotti, S., Maria Frezza, A., Demetri, G. D., Blay, J. Y., Bajpai, J., Baldi, G. G., Baldini, E. H., Benjamin, R. S., Bonvalot, S., Bovee, Jvmg, Callegaro, D., Casali, P. G., D'Angelo, S. P., Davis, E. J., Dei Tos, A. P., Demicco, E. G., Desai, J., Dileo, P., Eriksson, M., Gelderblom, H., George, S., Gladdy, R. A., Gounder, M. M., Gupta, A. A., Haas, R., Hayes, A., Hohenberger, P., Jones, K. B., Jones, R. L., Kasper, B., Kawai, A., Kirsch, D. G., Kleinerman, E. S., Le Cesne, A., Maestro, R., Martin Broto, J., Maki, R. G., Miah, A. B., Palmerini, E., Patel, S. R., Raut, C. P., Razak, A. R. A., Reed, D. R., Rutkowski, P., Sanfilippo, R. G., Sbaraglia, M., Schaefer, I. M., Strauss, D. C., Strauss, S. J., Tap, W. D., Thomas, D. M., Trama, A., Trent, J. C., van der Graaf, W. T. A., van Houdt, W. J., von Mehren, M., Wilky, B. A., Fletcher, C. D. M., Gronchi, A., Miceli, R., Wagner, A. J.: Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments Cancer Treat Rev 110 : 102455,2022.
Nathenson, M. J., Hu, J., Ratan, R., Somaiah, N., Hsu, R., DeMaria, P. J., Catoe, H. W., Pang, A., Subhawong, T. K., Amini, B., Sweet, K., Feister, K., Malik, K., Jagannathan, J., Braschi-Amirfarzan, M., Sheren, J., Caldas, Y., Moreno Tellez, C., Rosenberg, A. E., Lazar, A. J., Maki, R. G., Benedetto, P., Cohen, J., Trent, J. C., Ravi, V., Patel, S., Wilky, B. A.: Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study Clin Cancer Res 28 (18): 4092-4104,2022.
Coppock, J. D., Schneider, M. A., Surrey, L. F., Karakousis, G. C., Maki, R. G., Cooper, K.: S100 and CD34 Expressing Mesenchymal Neoplasm With Rare PLEKHH2::ALK Fusion and Response to ALK Inhibition Am J Surg Pathol 46 (9): 1309-1313,2022.
Maki, R. G., Grohar, P. J., Antonescu, C. R.: Ewing sarcoma and related FET family translocation-associated round cell tumors: A century of clinical and scientific progress Genes Chromosomes Cancer 61 (8): 509-517,2022.
Attia, S., Bolejack, V., Ganjoo, K. N., George, S., Agulnik, M., Rushing, D., Loggers, E. T., Livingston, M. B., Wright, J., Chawla, S. P., Okuno, S. H., Reinke, D. K., Riedel, R. F., Davis, L. E., Ryan, C. W., Maki, R. G.: A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results Cancer Med 10 : 2022.
Henry, D. H., Maki, R. G.: Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma Clin Cancer Res 28 (12): 2485-2487,2022.
View all publications
Academic Contact Information
Abramson Cancer Center
3400 Civic Center Blvd
Philadelphia,
PA
19104
Phone: 215-615-1594
Patient appointments: 800-789-7366